West Pharmaceutical Services

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell WST and other ETFs, options, and stocks.

About WST

West Pharmaceutical Services, Inc. engages in the manufacture and marketing of pharmaceuticals, biologics, vaccines, and consumer healthcare products. It operates through the Proprietary Products and Contract-Manufactured Products segments. 

CEO
Eric Mark Green
CEOEric Mark Green
Employees
10,600
Employees10,600
Headquarters
Exton, Pennsylvania
HeadquartersExton, Pennsylvania
Founded
1923
Founded1923
Employees
10,600
Employees10,600

WST Key Statistics

Market cap
18.02B
Market cap18.02B
Price-Earnings ratio
35.88
Price-Earnings ratio35.88
Dividend yield
0.35%
Dividend yield0.35%
Average volume
1.41M
Average volume1.41M
High today
$250.52
High today$250.52
Low today
$242.14
Low today$242.14
Open price
$244.43
Open price$244.43
Volume
980.27K
Volume980.27K
52 Week high
$322.34
52 Week high$322.34
52 Week low
$187.43
52 Week low$187.43

Stock Snapshot

As of today, West Pharmaceutical Services(WST) shares are valued at $250.49. The company's market cap stands at 18.02B, with a P/E ratio of 35.88 and a dividend yield of 35.3%.

On 2026-02-13, West Pharmaceutical Services(WST) stock traded between a low of $242.14 and a high of $250.52. Shares are currently priced at $250.49, which is +3.4% above the low and -0.0% below the high.

West Pharmaceutical Services(WST) shares are trading with a volume of 980.27K, against a daily average of 1.41M.

During the past year, West Pharmaceutical Services(WST) stock moved between $187.43 at its lowest and $322.34 at its peak.

During the past year, West Pharmaceutical Services(WST) stock moved between $187.43 at its lowest and $322.34 at its peak.

WST News

TipRanks 10h
West Pharmaceutical price target lowered to $300 from $370 at BofA

BofA lowered the firm’s price target on West Pharmaceutical (WST) to $300 from $370 and keeps a Buy rating on the shares after “a solid finish to the year” and...

The Motley Fool 2d
West Pharma Q4 2025 Earnings Call Transcript

Image source: The Motley Fool. Thursday, Feb. 12, 2026 at 8 a.m. ET CALL PARTICIPANTS Chief Executive Officer — Eric M. Green Chief Financial Officer — Robert...

West Pharma Q4 2025 Earnings Call Transcript
TipRanks 2d
West Pharmaceutical Services Posts Solid Q4 and 2025 Results

West Pharmaceutical Services ( (WST) ) has provided an announcement. West Pharmaceutical Services reported fourth‑quarter 2025 net sales of $805.0 million, up...

Analyst ratings

81%

of 16 ratings
Buy
81.3%
Hold
18.8%
Sell
0%

More WST News

Nasdaq 2d
West Pharmaceutical Q4 Earnings Rise; Guides FY26

(RTTNews) - West Pharmaceutical Services, Inc. (WST), on Thursday, reported its higher net income in the fourth quarter compared with the previous year and issu...

West Pharmaceutical Q4 Earnings Rise; Guides FY26
TipRanks 2d
West Pharmaceutical reports Q4 adjusted EPS $2.04, consensus $1.83

Reports Q4 revenue $805M, consensus $794.8M. “Our strong finish to 2025 was a result of the team’s relentless execution of our growth strategy,” said Eric Green...

Nasdaq 2d
West Pharmaceutical Services Inc. Q4 Income Rises

(RTTNews) - West Pharmaceutical Services Inc. (WST) released a profit for its fourth quarter that Increases, from the same period last year The company's botto...

West Pharmaceutical Services Inc. Q4 Income Rises
Simply Wall St 2d
Evaluating West Pharmaceutical Services Valuation As Earnings And GLP 1 Growth Stay In Focus

Advertisement Why West Pharmaceutical Services Is Back in Focus Ahead of Earnings West Pharmaceutical Services (WST) is drawing fresh attention as investors l...

Evaluating West Pharmaceutical Services Valuation As Earnings And GLP 1 Growth Stay In Focus
Simply Wall St 5d
Is It Time To Revisit West Pharmaceutical Services After Recent Share Price Rebound?

If you are wondering whether West Pharmaceutical Services is fairly priced or offering value right now, looking at a clear, structured view of its valuation can...

Is It Time To Revisit West Pharmaceutical Services After Recent Share Price Rebound?

People also own

Based on the portfolios of people who own WST. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.